45
Views
0
CrossRef citations to date
0
Altmetric
Letter

Oral available agents in the treatment of RRMS

Pages 199-201 | Published online: 29 Oct 2013

References

  • ThöneJEllrichmannGOral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culpritsDrug Healthc Patient Saf20135374723459383
  • BharatAXieFBaddleyJWIncidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseasesArthritis Care Res201264612615

References

  • RahmlowMShusterEADominikJLeflunomide-associated progressive multifocal leukoencephalopathyArch Neurol200865111538153919001176
  • BharatAXieFBaddleyJWIncidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseasesArthritis Care Res201264612615
  • LuEWangBWGuimondCSafety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilanceExpert Rev Neurother20131325126023448215